Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Should You Buy?

Shares of Anbio Biotechnology (NASDAQ:NNNN) gapped up before the market opened on Monday . The stock had previously closed at $12.35, but opened at $13.16. Anbio Biotechnology shares last traded at $12.6460, with a volume of 1,387 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Anbio Biotechnology currently has a consensus rating of “Hold”.

Anbio Biotechnology Stock Down 9.0%

The firm has a 50-day moving average price of $23.44.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.